GMP Bridge supports biopharma, biotech, and advanced therapy organizations in solving complex GMP and Quality challenges. From inspection readiness and contamination control to CDMO oversight, scalable Quality systems, and late-stage readiness, we help clients translate regulatory expectations into practical, risk-based solutions that work in real operations.
Our work is built around one objective: helping companies strengthen control, improve execution, and build systems that are credible under operational pressure and regulatory scrutiny.
At GMP Bridge, we help companies turn GMP and Quality requirements into systems that are clear, workable, and sustainable. Our approach combines senior expertise with hands-on execution, so improvements are not only well designed, but effective in daily operations and credible under inspection.
We work closely with client teams to identify the real gaps, define practical solutions, and support implementation where it matters most.
We start by understanding the operational reality, the risk landscape, and the critical weaknesses that need to be addressed.
We translate GMP expectations into structures, processes, and governance models that are usable, scalable, and easier to defend.
We work alongside client teams to help embed the right improvements in daily operations and strengthen long-term control.
Our work is guided by a few core principles: systems must work in practice, complexity should be reduced where possible, and Quality must remain strong under pressure.
If a system cannot support daily operations, it is not strong enough.
Clearer processes and responsibilities reduce risk and improve consistency.
Complex GMP challenges require people who have seen them before and know how to solve them.
A system that cannot stand up to inspection is not yet where it needs to be.
Felipe Fontanet is the Founder and Managing Director of GMP Bridge. With nearly two decades of experience in biopharma Quality, GMP compliance, and sterile manufacturing, he supports biotech, biopharma, and advanced therapy companies in solving complex operational and regulatory challenges. He leads and coordinates GMP Bridge’s senior consulting team, combining strategic oversight with hands-on support to help clients build systems that are robust, risk-based, and inspection-defensible.
Let's Discuss Your GMP Challenges